For professionals in the pharmaceutical and fine chemical industries, securing a consistent and high-quality supply of key intermediates is fundamental to operational success. 5-Chloro-2-(3,5-diMethyl-phenyl)-quinoline, known by its CAS number 1404491-66-2, is precisely such a compound – a crucial building block in advanced organic synthesis and drug development.

Understanding the market for this specific quinoline derivative involves identifying reputable manufacturers who can guarantee product purity and reliability. China has emerged as a leading global supplier of specialized chemical intermediates, offering a vast network of manufacturers capable of producing 5-Chloro-2-(3,5-diMethyl-phenyl)-quinoline to exacting standards. For procurement managers and research scientists, knowing where to buy this intermediate efficiently is a significant advantage.

When evaluating potential suppliers, it’s essential to consider factors beyond just price. A trusted manufacturer will provide detailed specifications, certificates of analysis, and demonstrate a commitment to quality control. The price of 5-Chloro-2-(3,5-diMethyl-phenyl)-quinoline can fluctuate based on market demand, raw material costs, and order volume. Therefore, engaging with multiple established suppliers and requesting comprehensive quotes for CAS 1404491-66-2 is a prudent strategy.

The chemical structure of 5-Chloro-2-(3,5-diMethyl-phenyl)-quinoline (C17H14ClN, MW 267.75276) is tailored for specific synthetic pathways, making it a valuable asset in R&D laboratories and large-scale production facilities. Its role as a pharmaceutical intermediate means that consistency and purity are paramount to ensure the efficacy and safety of the final pharmaceutical products.

We recommend leveraging the expertise of Chinese chemical manufacturers for your sourcing needs. By connecting with established suppliers, you can streamline your procurement process, obtain competitive pricing, and ensure a reliable supply of 5-Chloro-2-(3,5-diMethyl-phenyl)-quinoline. This strategic sourcing approach is critical for maintaining project momentum and achieving commercial success in the pharmaceutical sector.